This Government Contract opportunity from Department Of Defense was posted on May 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
FDA-Compliant Pharmaceutical Manufacturing (Antibiotic Injectable)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the manufacture of Clindamycin Phosphate Injection, USP, ensuring strict compliance with FDA, DLA, and military specifications. The scope encompasses production of sterile injectable pharmaceuticals with rigorous batch testing, quality assurance procedures, and complete documentation to meet regulatory and defense requirements. The contract is a subcontract opportunity under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The contracting agency is the Department of Defense's Medical Supply Chain Pharmacy Field Support Activity, with the place of performance listed as FPO, ZIP code 96607. The contract was posted on May 31, 2026, with responses due by June 8, 2026. It focuses on delivering high-quality antibiotic injectables to support defense medical supply chains, ensuring all manufacturing processes adhere to the necessary sterility and pharmaceutical standards for injectable drugs.
General Info
Agency
NAICS
Place of Performance
FPO, AP, 96607, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
